// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Derived Macrophages of Duchenne Muscular Dystrophy (mdx) Mice Are Differentially "Educated" Based on Muscle Disease Stage

S. Bhattarai - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Duchenne muscular dystrophy

N/A

Induced Diaphragm Atrophy in All Myofiber Types

K. Fernandez - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Diaphragm Thickening Fraction and Its Relation with Disease Severity and Symptoms in Patients with Chronic Obstructive Pulmonary Disease: Comparison of Measurements Performed During Tidal Breathing and Maximal Inspiration

A. Maynard-Paquette - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Differential DNA Methylation and Aging Patterns According to Regional COPD Severity in Lung Tissue

F. Xu - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Smokers Without COPD: Can Machine Learning Reveal Subclinical Disease?

A. R. Westcott - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

Can Machine Learning and MRI Identify COPD Patients at Risk of Accelerated Progression?

C. Ong Ly - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The Effect of Pulmonary Rehabilitation Following Acute Exacerbation of COPD on Cardiovascular Function

B. A. Ross - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Systemic inflammation

N/A

The Importance of Nutritional Support in Lung Transplant Candidates

K. Chohan - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Comparison of Medication Delivery from Nebulizers When Coupled to Oscillatory Positive Expiratory Pressure Devices

J. Suggett - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Carbocysteine

A Comparison of Oscillometry Devices in Pediatric Asthma, Bronchopulmonary Dysplasia and Healthy Children

M. Dumas - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Infant Respiratory Distress Syndrome

N/A

Bronchodilator Response in Children with Cystic Fibrosis Pulmonary Exacerbations

M. Pollak - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Pulmonary fibrosis

N/A

The Utility of Skeletal Muscle Cross Sectional Area and Nutritional Risk Index in Predicting Outcomes Across Patients with Hematologic Malignancy and Acute Respiratory Failure

M. D. Elfassy - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Acute respiratory failure

N/A

Critical Care Outcomes of Patients with Hematologic Malignancy (HM) and Hematopoietic Cell Transplant (HCT): A Canadian Multicenter Prospective Study

L. Munshi - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Acute respiratory failure

N/A

Validation of Individualized Prediction of Lung Function Decline in Patients Diagnosed with COPD

M. Kerkhof - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Asthma

N/A

1 Antitrypsin Deficiency Population Based on the Rate of FEV1 Decline and other Clinical Characteristics

S. Gurupatham - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Alpha-1-antitrypsin deficiency

N/A

Facilitating Factors for Home and Hospice Deaths in Interstitial Lung Disease (ILD) Patients

N. Archibald - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Disparities in the Treatment of Patients with Interstitial Lung Disease in Canada

D. Assayag - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Interstitial lung disease

N/A

Advanced Care Planning (ACP) Model in Idiopathic Pulmonary Fibrosis

A. Daoud - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Idiopathic pulmonary fibrosis

N/A

Magnetic Resonance Spectroscopy of Hyperpolarized 129Xe in a Rat Model of Bronchopulmonary Dysplasia: Effect on Red Blood Cell Chemical Shift in the Lungs

Y. Friedlander - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Q): A Validation Study for Lung Histology Quantification in Rodent Models of Bronchopulmonary Dysplasia

A. Lindenmaier - American Thoracic Society (ATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Infant Respiratory Distress Syndrome

N/A

Copyright © 2026. QuantiNova All rights reserved